Characteristics of Medalist study participants
| Male (%) | 47.0 (192) |
| A1C (%) | 7.3 ± 1.1 |
| Age (years) | 67.2 ± 7.4 |
| Age at diagnosis (years) | 11.0 ± 6.5 |
| Duration (years) | 56.2 ± 5.8 |
| BMI (kg/m2) | 26.0 ± 5.1 |
| C-peptide (nmol/l) | 0.07 ± 0.12 |
| Cholesterol (mmol/l) | 4.2 ± 0.9 |
| Calculated HDL (mmol/l) | 1.6 ± 0.5 |
| LDL (mmol/l) | 2.2 ± 0.6 |
| Triglycerides (mmol/l) | 0.9 ± 0.5 |
| Insulin dose (u/kg) | 0.46 ± 0.2 |
| Family history of diabetes | |
| Any diabetes | 29.7 (122) |
| Type 1 diabetes | 12.9 (53) |
| DR3* | 38.8 (116) |
| DR4* | 52.0 (156) |
| DR3 or DR4* | 93.7 (295) |
| DR3/4* | 39.1 (118) |
| IA2 or GAD* | 29.7 (111) |
| IA2* | 14.9 (56) |
| GAD* | 18.4 (69) |
| Proliferative diabetic retinopathy* | 55 (163) |
| Microalbuminuria (ACR <7.91)* | 13.1 (45) |
| Neuropathy (MNSI >2)* | 60.6 (183) |
| Cardiovascular disease* | 48.3 (160) |
Data are means ± SD or % (n).
*Percentages reflect calculations done on data available. ACR, albumin-to-creatinine ratio; MNSI, Michigan Neuropathy Screening Instrument.